PUT/MERCK & CO./110/0.1/20.09.24 Stock

Warrant

DE000GG0N7A8

Market Closed - BOERSE MUENCHEN 02:26:27 2024-06-26 pm EDT
0.041 EUR +5.13% Intraday chart for PUT/MERCK & CO./110/0.1/20.09.24
Current month-65.25%
1 month-38.81%
Date Price Change
24-06-26 0.041 +5.13%
24-06-25 0.039 -13.33%
24-06-24 0.045 -11.76%
24-06-21 0.051 0.00%
24-06-20 0.051 -15.00%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 02:26 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GG0N7A
ISINDE000GG0N7A8
Date issued 2023-12-04
Strike 110 $
Maturity 2024-09-20 (86 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1
Lowest since issue 0.038
Spread 0.02
Spread %31.25%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus